Overexpression of ERG may also follow fusion with other genes including SLC45A3, FOXP1, and HERV-K, among others however, this is seen in only about 10% of cases of prostate cancer with ERG overexpression [11]. The gene discussed is ERG; the disease is prostate carcinoma.